Drugs (Prices Control) Order Matters
REDUCTION IN MAXIMUM RETAIL PRICE (MRP) OF SCHEDULED FORMULATION
In compliance with Order S.O. 6001(E) dated 2nd November 2026 issued by the National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Government of India, under Paragraphs 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices Control) Order, 2013, the ceiling price of the scheduled formulation Oxaliplatin Injection 5 mg/mL in 10 mL vial (1 vial) has been fixed/revised at ₹2285.84 (exclusive of GST). Accordingly, RPG LIFE SCIENCES LTD. has reduced the MRP of the products. The revised MRPs are effective with immediate effect.